Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

10.15
-0.5500-5.14%
Volume:28.17K
Turnover:308.86K
Market Cap:19.76M
PE:-0.64
High:11.40
Open:10.53
Low:10.15
Close:10.70
52wk High:49.60
52wk Low:3.02
Shares:1.95M
Float Shares:1.37M
Volume Ratio:1.37
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.9015
EPS(LYR):-20.5537
ROE:-140.09%
ROA:-19.10%
PB:1.06
PE(LYR):-0.49

Loading ...

European Equities Traded in the US as American Depositary Receipts Track Sharply Higher in Thursday Trading

MT Newswires Live
·
Jul 30

European Equities Traded in US as ADRs Ease in Wednesday Trading

MT Newswires Live
·
Jul 29

European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading

MT Newswires Live
·
Jul 27

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live
·
Jul 22

Akari Therapeutics Enters Strategic ADC Payload Research Collaboration with Whitehawk Therapeutics

Reuters
·
Jul 22

Akari Therapeutics Enters Preclinical ADC Research Collaboration with Whitehawk Therapeutics

Reuters
·
Jul 21

Akari Therapeutics - Collaboration to Commence Immediately with Interim Data Updates Anticipated

THOMSON REUTERS
·
Jul 21

Akari Therapeutics - Co and Whitehawk to Conduct Preclinical Studies of Ph1 Payload with Top1i ADC Platform

THOMSON REUTERS
·
Jul 21

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

THOMSON REUTERS
·
Jul 21

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Jul 20

Maxim upgrades Akari Therapeutics to Buy on AKTX-101 data, ADC M&A

TIPRANKS
·
Jul 20

Akari Therapeutics Plc : Maxim Group Raises to Buy from Hold

THOMSON REUTERS
·
Jul 20

European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading

MT Newswires Live
·
Jul 08

Akari Therapeutics (AKTX) Stock Rallies on a Scientific Advisory Board Addition

TIPRANKS
·
Jul 08

Akari Therapeutics Appoints Former Aacr President and Renowned Oncology Drug Development Leader, Patricia Lorusso, D.o., to Scientific Advisory Board

THOMSON REUTERS
·
Jul 07

Press Release: Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia Lorusso, D.O., to Scientific Advisory Board

Dow Jones
·
Jul 07

Akari Therapeutics Publishes 2025 Annual Report

Reuters
·
Jul 07

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Jul 06

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 06

Akari Therapeutics Holds Annual General Meeting, Shareholders Vote on Director Re-elections

Reuters
·
Jul 03